Literature DB >> 21288837

Implementation of cocooning against pertussis in a high-risk population.

C Mary Healy1, Marcia A Rench, Carol J Baker.   

Abstract

BACKGROUND: In 2006, the Advisory Committee on Immunization Practices recommended tetanus, diphtheria, acellular pertussis (Tdap) vaccination of all caregivers of infants aged <1 year ("cocooning") to prevent pertussis-related complications and deaths. We implemented cocooning in a predominantly Hispanic, medically underserved, uninsured population at a Houston hospital. Phase 1 (January 2008-January 2010) provided maternal postpartum Tdap vaccine; Phase 2 (June 2009-January 2010) also vaccinated infant contacts on-site.
METHODS: Pertussis education was provided to health care personnel and mothers. Standing orders for maternal postpartum Tdap vaccination were initiated. Mothers were interviewed to ascertain the number of additional infant contacts eligible to receive Tdap vaccine. Consenting eligible contacts received Tdap vaccine as soon as possible after delivery.
RESULTS: From 7 January 2008 through 31 January 2010, 8334 (75%) of 11,174 postpartum women received Tdap vaccine. During Phase 2, 2969 (86%) of 3455 postpartum women were vaccinated; another 197 (6%) had previously received Tdap vaccine. Mothers were Hispanic (91.4%), black (5.4%), white (0.8%), Asian (1.4%) and other (1.0%). A median of 3 (range, 1-11) other Tdap-eligible contacts per infant were identified, and a median of 2 (range, 0-10) contacts per infant received Tdap vaccine. Of 1860 contacts vaccinated, 1813 (98%) anticipated daily infant contact. A total of 1697 (91%) received Tdap vaccine before infant hospital discharge, and 144 (8%) received Tdap vaccine within 7 days after hospital discharge. Barriers to full cocooning included the need for extended vaccination hours, visiting restrictions because of pandemic H1N1 influenza, and inaccurate recall of vaccination history.
CONCLUSION: Although practical and logistical barriers exist, Tdap cocooning was well accepted by and successfully implemented in a high-risk population by using standing orders and providing vaccinations on-site.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21288837     DOI: 10.1093/cid/ciq001

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  34 in total

1.  The National Vaccine Advisory Committee: reducing patient and provider barriers to maternal immunizations: approved by the National Vaccine Advisory Committee on June 11, 2014.

Authors: 
Journal:  Public Health Rep       Date:  2015 Jan-Feb       Impact factor: 2.792

2.  Incorporating immunizations into routine obstetric care to facilitate Health Care Practitioners in implementing maternal immunization recommendations.

Authors:  Heather Webb; Jackie Street; Helen Marshall
Journal:  Hum Vaccin Immunother       Date:  2014-02-07       Impact factor: 3.452

3.  Potential impact of parental Tdap immunization on infant pertussis hospitalizations.

Authors:  Timothy R Peters; Gretchen C Banks; Beverly M Snively; Katherine A Poehling
Journal:  Vaccine       Date:  2012-06-27       Impact factor: 3.641

4.  Understanding the barriers to uptake of antenatal vaccination by women from culturally and linguistically diverse backgrounds: A cross-sectional study.

Authors:  Sushena Krishnaswamy; Allen C Cheng; Euan M Wallace; Jim Buttery; Michelle L Giles
Journal:  Hum Vaccin Immunother       Date:  2018-03-26       Impact factor: 3.452

5.  Protecting newborns by immunizing family members in a hospital-based vaccine clinic: a successful Tdap cocooning program during the 2010 California pertussis epidemic.

Authors:  Elizabeth Rosenblum; Sarah McBane; Wendy Wang; Mark Sawyer
Journal:  Public Health Rep       Date:  2014-05       Impact factor: 2.792

Review 6.  Immunization During Pregnancy: Impact on the Infant.

Authors:  Kirsten P Perrett; Terry M Nolan
Journal:  Paediatr Drugs       Date:  2017-08       Impact factor: 3.022

7.  Maternal and neonatal vaccination protects newborn baboons from pertussis infection.

Authors:  Jason M Warfel; James F Papin; Roman F Wolf; Lindsey I Zimmerman; Tod J Merkel
Journal:  J Infect Dis       Date:  2014-02-12       Impact factor: 5.226

Review 8.  Prevention of pertussis through adult vaccination.

Authors:  Manika Suryadevara; Joseph B Domachowske
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

9.  Increased awareness and health care provider endorsement is required to encourage pregnant women to be vaccinated.

Authors:  J Collins; I Alona; R Tooher; H Marshall
Journal:  Hum Vaccin Immunother       Date:  2014-11-21       Impact factor: 3.452

10.  Cost-Effectiveness of Pertussis Vaccination During Pregnancy in the United States.

Authors:  Katherine E Atkins; Meagan C Fitzpatrick; Alison P Galvani; Jeffrey P Townsend
Journal:  Am J Epidemiol       Date:  2016-05-13       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.